1. Home
  2. REZI vs IMVT Comparison

REZI vs IMVT Comparison

Compare REZI & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resideo Technologies Inc.

REZI

Resideo Technologies Inc.

HOLD

Current Price

$40.15

Market Cap

5.3B

Sector

Industrials

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$27.08

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REZI
IMVT
Founded
2018
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.8B
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
REZI
IMVT
Price
$40.15
$27.08
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
$39.67
$33.00
AVG Volume (30 Days)
1.1M
1.5M
Earning Date
05-12-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,472,000,000.00
N/A
Revenue This Year
$6.81
N/A
Revenue Next Year
$3.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.52
N/A
52 Week Low
$17.22
$13.36
52 Week High
$45.29
$30.09

Technical Indicators

Market Signals
Indicator
REZI
IMVT
Relative Strength Index (RSI) 59.99 51.37
Support Level $39.36 $24.63
Resistance Level $43.30 $27.71
Average True Range (ATR) 1.17 1.35
MACD 0.01 -0.13
Stochastic Oscillator 63.54 40.67

Price Performance

Historical Comparison
REZI
IMVT

About REZI Resideo Technologies Inc.

Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: